In the aorta, aggrecan degradation is likely to be due to increase in the activity and expression of aortic MMP-2, MMP-9 and Calpain-1 with advancing age33–37, whilst increased ADAMTS levels promote thoracic aortic aneurysm progression38. Here, MMP9 is linked to thoracic aortic aneurysm.